NCT06636500View on ClinicalTrials.gov

A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

September 30, 2025

Conditions
Healthy Volunteer StudyPain Management
Interventions
DRUG

CG001419

Oral doses

DRUG

Placebo

Oral doses

Trial Locations (1)

5000

RECRUITING

CMAX Clinical Research, Adelaide

All Listed Sponsors
lead

Cullgen Australia Pty Ltd

INDUSTRY